Applying a Bioisosteric Replacement Strategy in the Discovery and Optimization of Mesoionic Pyrido[1,2-a]pyrimidinone
Wenming Zhang1, George P Lahm1, Thomas F Pahutski1
1Stine Research Center, FMC Ag Solutions, 1090 Elkton Road, Newark, Delaware 19711, United States.
Journal of Agricultural and Food Chemistry
|April 8, 2022
Summary
Researchers discovered novel insecticidal compounds derived from mesoionic pyrido[1,2-a]pyrimidinones. Optimization led to dicloromezotiaz, an effective agent against various lepidopteran pests.
Area of Science:
- Agrochemical Science
- Medicinal Chemistry
- Organic Synthesis
Background:
- Mesoionic pyrido[1,2-a]pyrimidinones represent a unique heterocyclic scaffold.
- Initial screening identified compounds with insecticidal properties, particularly those with an n-propyl group at the 1-position.
Purpose of the Study:
- To explore the structure-activity relationships of mesoionic pyrido[1,2-a]pyrimidinones for insecticidal applications.
- To discover and optimize novel insecticidal agents through bioisosteric replacement strategies.
Main Methods:
- Systematic exploration of substituents at the 1-position of the mesoionic core.
- Evaluation of diverse mesoionic bicyclic ring scaffolds.
- Modification of substituents on the phenyl group at the 3-position and the mesoionic ring skeleton.
Main Results:
- Discovery of numerous compounds exhibiting significant hopper activity.
- Identification of potent insecticides effective against a broad range of Lepidoptera.
- Dicloromezotiaz emerged as a lead candidate for commercial development.
Conclusions:
- Bioisosteric replacement is a viable strategy for discovering potent insecticides within this chemical class.
- The optimized compounds demonstrate broad-spectrum efficacy against key agricultural pests.
- Dicloromezotiaz shows promise for controlling lepidopteran pests in agriculture.
Related Concept Videos
Drug Discovery: Overview
9.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.1K
Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Nucleophilic Aromatic Substitution of Aryldiazonium Salts: Aromatic SN1
2.2K
Treating arylamines with nitrous acid gives aryldiazonium salts that are effective substrates in nucleophilic aromatic substitution reactions. The diazonio group in these salts can be easily displaced by different nucleophiles, yielding a wide variety of substituted benzenes. The leaving group departs as nitrogen gas, and this easy elimination is the driving force for the substitution reaction.
In the Sandmeyer reaction, for example, the diazonio group is replaced by a chloro, bromo,...
In the Sandmeyer reaction, for example, the diazonio group is replaced by a chloro, bromo,...
2.2K
Basicity of Heterocyclic Aromatic Amines
6.3K
Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).
6.3K


